Baeshen NA, Baeshen MN, Sheikh A, Bora RS, Ahmed MM, Ramadan HA, et al
As well as Mourjaro, Novo Nordisk drug, Wegovy, is widely used in the UK
91% reported reduced overall food cravings and 88% reported reduced sugar cravings
Although initial glycemic control was similar between the two populations, subcutaneous OW semaglutide was more frequently prescribed as an intensification of therapy than oral semaglutide, and it was more commonly used in add-on to metformin
Clinical Trials and Efficacy In clinical trials, patients taking 7.2 mg of Wegovy lost 20.7% of their body weight compared to 17.5% with the current 2.4 mg dose over 72 weeks
So close you can hear them talking and hammering in the voice recording